UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
February 14, 2006
PROXYMED, INC.
(Exact name of registrant as specified in its charter)
| |
|
|
|
|
Florida
(State or other
jurisdiction of
incorporation)
|
|
000-22052
(Commission File No.)
|
|
65-0202059
(IRS Employer
Identification No.) |
1854 Shackleford Court, Suite 200,
Norcross, Georgia 30093-2924
(Address of principal executive offices)
(770) 806-9918
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
Item 8.01 Other Events.
On February 14, 2006, ProxyMed, Inc., d/b/a MedAvant Healthcare Solutions (the “Company”),
issued a press release announcing that the Company acquired substantially all the assets and
operations of Zeneks, Inc., a privately held bill negotiation services company based in Tampa,
Florida.
The description of the press release set forth above is qualified in its entirety by reference
to the press release, a copy of which is attached to this Current Report on Form 8-K as Exhibit
99.1
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
The following exhibits are filed with this Current Report on Form 8-K:
| |
|
|
| Exhibit No. |
|
Description |
| |
99.1
|
|
Press release of the Company dated February 14, 2006. |
2